Therefore, treatment with medicines, which promote glucose metabolism, enhance insulin signaling and reduce oxidative stress, might contribute to ameliorate the viability and function of brain neurons at the risk of AD neurodegeneration. This evidence concerns the gene INS and Alzheimer disease.